CorVista Health Demonstrates High-Sensitivity for Noninvasive Detection of CAD including INOCA (Ischemia with No Obstructed Coronary Arteries) at ACC.26

Machine-learning physiologic signal model achieved 90% sensitivity and 99% negative predictive value for ischemia detection in symptomatic patients The model showed strong sensitivity in both ...
TCTMD

Stress Testing Picks Up ‘Novel Risk Patterns’ in Stable CAD Patients: ISCHEMIA

Stress testing results—no matter the modality used to obtain them—predict prognosis among patients with stable, moderate-to-severe CAD, new data from the ISCHEMIA trial suggest. The study, published ...
MarketWatch

CorVista Health to Present New Data on Non-Invasive Point of Care Test for Ischemia with Non-Obstructive Coronary Arteries Using Machine Learning at ACC.26

CorVista Health today announced the upcoming poster presentation of new data on its non-invasive point of care test for ischemia with non-obstructive coronary arteries (INOCA) -- a common condition, ...
TCTMD

ISCHEMIA Questions? Some Answers From David Maron

I n the month since its presentation at the American Heart Association 2019 Scientific Sessions, the ISCHEMIA trial has continued to generate discussion and debate. The trial was presented to a packed ...
Yahoo Finance

CorVista Health to Present New Data on Non-Invasive Point of Care Test for Ischemia with Non-Obstructive Coronary Arteries Using Machine Learning at ACC.26

CorVista Health will be exhibiting in the Future Hub Booth #FH8, where attendees can learn about the CorVista System. The CorVista System is an FDA-cleared, non-invasive cardiovascular diagnostics ...
Morningstar

CorVista Health to Present New Data on Non-Invasive Point of Care Test for Ischemia with Non-Obstructive Coronary Arteries Using Machine Learning at ACC.26

CorVista Health to Present New Data on Non-Invasive Point of Care Test for Ischemia with Non-Obstructive Coronary Arteries Using Machine Learning at ACC.26 CorVista Health today announced the upcoming ...